Risks and Benefits of Interferon-α in the Treatment of Hepatitis
1995
The high worldwide prevalence of chronic viral hepatitis, as well as its progressive course, have led to the performance of multiple clinical studies. The natural history of the disease is different depending on the infecting virus; thus, the evolution to liver cirrhosis and/or hepatocellular carcinoma for the hepatitis B, C and delta (D) viruses in chronic hepatitis is 15, 20 and 75%, respectively. Different therapeutic agents have been used in attempts to modify the natural course of these diseases, interferon-α (IFNα) having proved to be the most effective.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
134
References
22
Citations
NaN
KQI